Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Merck NYSE:MRK |
298,84 B | 7,67% | 6/6 | -21,36% | -11,14% | 9,21% | UP |
|
Pfizer NYSE:PFE |
161,09 B | 7,82% | 4/6 | -5,31% | 18,13% | -4,66% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
121,69 B | 1,77% | 5/6 | -0,30% | -2,46% | 7,38% | UP |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
78,18 B | 9,26% | 5/6 | 5,41% | 3,03% | 14,85% | UP |
|
Moderna NasdaqGS:MRNA |
19,51 B | 12,29% | 2/6 | 22,84% | -579,61% | -17,68% | UP |
|
Genmab A/S CPSE:GMAB |
107,96 B | 14,29% | 4/6 | -4,48% | 52,86% | 33,64% | DOWN |
|
Immunocore Holdings NasdaqGS:IMCR |
1,56 B | 53,28% | 5/6 | 12,68% | 31,80% | 101,10% | DOWN |
|
Iovance Biotherapeutics NasdaqGM:IOVA |
1,41 B | 0,00% | 1/4 | 43,83% | -61,28% | 176,97% | UP |
|
Replimune Group NasdaqGS:REPL |
0,69 B | 0,00% | 0/4 | 0,00% | 0,00% | 42,69% | DOWN |
